PEPperPRINT is an innovative biotechnology company based in Heidelberg, Germany. As a leading provider of high-throughput peptide and protein microarray technologies, the company focuses on antibody characterization and antibody response fingerprint profiling in biological samples.By expanding its portfolio with T-cell epitope mapping and monitoring services, PEPperPRINT has established a comprehensive product and service matrix, positioning itself as a one-stop solution provider for immune response fingerprint analysis.PEPperPRINT offers the advanced PEPperCHIP® peptide microarray platform, which is widely applied in antigen and epitope discovery, epitope mapping analysis, epitope substitution scanning, immune monitoring, serum biomarker discovery, and peptide-targeted binder development.The company’s product portfolio includes PEPperCHIP® peptide microarrays, PEPperMAP® services, T-cell services, synthetic peptides, and protein microarrays.
Vicbio Biotechnology Co., Ltd. provides the full range of PEPperPRINT products.
⇨ Inquire or Order immediately ⇦
•Custom Peptide Microarrays: Microarrays synthesized according to specific customer requirements, containing defined peptide sequences. These arrays can be used for various research applications, including antigen epitope identification and protein interaction studies.
•Standard Peptide Microarrays: A range of pre-designed peptide microarrays covering commonly studied protein sequences or functional regions, enabling researchers to quickly initiate experiments.
•Microarray Accessories: Supporting accessories for microarray experiments, such as chip carriers, sealing devices, and other related components, ensuring smooth and reliable experimental workflows.
•Antibody Services: Including antibody epitope mapping, affinity analysis, and specificity profiling, helping researchers gain deeper insights into antibody characteristics and functionality.
•Serum+ Services: Comprehensive analysis services for serum samples, including antibody repertoire profiling and disease biomarker discovery, supporting disease diagnostics and biomedical research.
•Protein Services: Services such as protein interaction analysis and protein functional site identification, facilitating advanced proteomics research.
Specialized services focused on T-cell-related research, including T-cell epitope identification and T-cell immune response analysis. These services play an important role in immunotherapy development and vaccine research.
PEPperPRINT provides custom peptide synthesis services, capable of producing peptides of various lengths and sequences to meet the needs of protein chemistry research, drug discovery, and related applications.
PEPperPRINT offers protein microarray products and services for high-throughput protein functional analysis and interaction studies.
| Product Name | Peptide length and overlap |
| African Swine Fever Virus Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| BK Polyomavirus Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Chikungunya Virus Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Dengue Virus Type 1 Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Dengue Virus Type 2 Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Dengue Virus Type 3 Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Dengue Virus Type 4 Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Epstein-Barr Virus Peptide Microarray | 13 aa peptides with peptide-peptide overlap of 11 aa (shift 2) |
| Foot-and-mouth Disease Virus Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| HBV L-Protein Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| HBV Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 12 aa (shift 3) |
| HCMV Antigen Microarray | 15 aa peptides with a peptide-peptide overlap of 12 aa (shift 3) |
| HCV Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 12 aa (shift 3) |
| HIV-1 (Env) Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| hMPV Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| HSV-1 Proteome Microarray | 15 aa peptides with an overlap of 13 aa (shift 2) |
| Infectious Disease Epitope Microarray | 4 aa - 17 aa depending on the database epitope length; longer epitopes were translated into overlapping 17 aa peptides |
| Influenza Virus H1N1 Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| Influenza Virus H5N1 Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 10 aa (shift 5) |
| Japanese Encephalitis Virus Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| MERS-CoV Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa amd 12 aa (shift 2 and 3) |
| Mpox Virus Peptide Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| Mycobacterium Tuberculosis Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Neglected Tropical Diseases Peptide Microarray | 3 to 15 aa peptides with peptide-peptide overlap of 14 aa for epitopes with more than 15 aa |
| Pan-corona Spike Protein Microarray | |
| SARS Coronavirus Proteome Microarray | 15 aa peptides with a peptide-peptide overlap of 13 aa (shift 2) |
| SARS-CoV Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| SARS-CoV-2 Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| Tetanus Toxin Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Tick-borne Encephalitis Virus Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Trypanosoma Brucei Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Vaccinia Virus Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| West Nile Virus Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Yellow Fever Virus Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Zika Virus Proteome Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Allergen Epitope Microarray | 5 aa to 17 aa depending on the database epitope length; longer epitopes were translated into overlapping 17 aa peptides. |
| Autoimmune Epitope Microarray | 3 aa to 17 aa depending on the epitope length; longer epitopes were translated into overlapping 17 aa peptides |
| Autoimmune Human Epitope Microarray | 4 aa to 17 aa depending on the epitope length; longer epitopes were translated into overlapping 17 aa peptides |
| CNS Peptide Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| Cyclic Citrullinated Peptide Microarray | 10 aa - 17 aa cyclic constrained peptides via N- to C-terminal thioether formation |
| Human Cytokine Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Lupus Microarray | 3 aa to 15 aa |
| Transglutaminase Peptide Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| CRISPR/Cas Immunogenicity Microarray | 15 aa peptides with peptide-peptide overlap of 14 aa (shift 1) |
| Pan-AAV Capsid Protein Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| Cancer Neoepitope Microarray | 3 aa to 15 aa depending on the epitope length |
| Melanoma Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| Oncovirus Epitope Microarray | 3 aa to 20 aa depending on the epitope length; longer epitopes were translated into overlapping 20 aa peptides |
| Tumor Antigen Microarray | 15 aa peptides with peptide-peptide overlap of 13 aa (shift 2) |
| Human Epitome Microarray | 5 to 17 aa depending on the epitope length; longer epitopes were translated into overlapping 17 aa peptides |
| Signature Microarray | 15 aa peptides |
| Signature Discovery Microarray | 15 aa |
